Search - tctmd.com

Displaying 861 - 880 of 1882

Sort: Relevancy | Date

News Daily News

Dedicated Coronary Teams May Be Key to Optimizing CABG Outcomes

L.A. McKeown

July 27, 2018

News Daily News

CMS Advisory Panel Splits on TAVR Volume Requirements

Todd Neale

July 26, 2018

Story 2: STS Data: Mitral Valve Cases Are Fastest-Growing Surgical Intervention in North America

News Daily News

STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America

L.A. McKeown

July 25, 2018

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Shelley Wood

July 23, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Daily News

Medicare’s Bundled Payments Plan Hasn’t Cut Costs (Yet)

Caitlin E. Cox

July 18, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Michael O'Riordan

June 27, 2018

News Conference News The Structural Heart Disease Summit 2018

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Shelley Wood

June 22, 2018

News Daily News

‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers

Yael L. Maxwell

June 20, 2018

News Daily News

VTE Risk Higher in Surgical Patients Who Get Transfusions

Todd Neale

June 13, 2018

News Daily News

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

Caitlin E. Cox

June 11, 2018

News Daily News

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

Caitlin E. Cox

June 07, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

News Conference News HRS 2018

Botox Injections Around the Heart Have Lasting Impact on Suppressing A-fib After CABG

Todd Neale

May 14, 2018

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

L.A. McKeown

May 11, 2018

Advertisement

Dedicated Coronary Teams May Be Key to Optimizing CABG Outcomes

CMS Advisory Panel Splits on TAVR Volume Requirements

STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Medicare’s Bundled Payments Plan Hasn’t Cut Costs (Yet)

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Once Again, ISCHEMIA Trial Feels the Squeeze

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers

VTE Risk Higher in Surgical Patients Who Get Transfusions

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Pace Quickens for Mitral Device Innovation for Repair, Replacement

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Botox Injections Around the Heart Have Lasting Impact on Suppressing A-fib After CABG

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content